Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research.

Current Issue

February 2023 (Vol. 43 Issue 2) Table of Contents
Anticancer Research: 43 (2)

Issue highlights

  • Treatment of Human Pancreatic Cancers Following Local and Systemic Administration of Oncolytic Adenovirus Serotype 35
  • Contrast-enhanced Ultrasound Using Intradermal Microbubble Sulfur Hexafluoride for Identification of Sentinel Lymph Nodes During Breast Cancer Surgery: A Clinical Trial
  • Ki67 and E-cadherin Are Independent Predictors of Long-term Survival in Endometrial Carcinoma
  • Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study
  • Refined Diagnosis of Pleural Effusions by Immunocytochemistry of Cell Blocks

Special Issue of ANTICANCER RESEARCH

on NEW ANTICANCER AGENTS

Topics:

A. Experimental studies on “Νew Anticancer Agents”

1. Synthesis and evaluation in vitro and in vivo
2. Mechanism of action
3. Reversal of resistance to anticancer agents
4. Oncolytic viruses

B. Clinical studies on “New Anticancer Agents”

1. Pharmacology
2. Clinical trials
3. Combination chemotherapy
4. Immunotherapeutic agents
5. New methodologies in drug delivery
6. Vaccines

Publication date: March 2, 2023; Submission deadline: December 30, 2022

Instructions for the preparation and submission of reviews and original articles.


Featured Articles

  • Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Soft-tissue Sarcoma More Closely...
    February 09, 2015
  • Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and...
    September 25, 2015
  • The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in...
    December 31, 2019
  • Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a...
    December 30, 2014
  • Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-...
    December 30, 2014
  • A Long Noncoding RNA, lncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer
    March 06, 2015

Latest Articles

  • You have access
    Prognostic Significance of Preoperative Nutritional Assessment in Elderly Patients who Underwent Laparoscopic Gastrectomy for Stage I-III Gastric Cancer
    HIDEO UEHARA, MITSUHIKO OTA, MANABU YAMAMOTO, TOMONORI NAKANOKO, YUKI SHIN, KEIICHI SHIOKAWA, YOSHIAKI FUJIMOTO, YUICHIRO NAKASHIMA, MASAHIKO SUGIYAMA, EMI ONISHI, TOMONARI SHIMAGAKI, YOHEI MANO, KEISHI SUGIMACHI, MASARU MORITA and YASUSHI TOH
    Anticancer Research February 2023, 43 (2) 893-901; DOI: https://doi.org/10.21873/anticanres.16232
  • You have access
    Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic Colorectal Cancer
    MING XU, RYOUICHI TSUNEDOMI, KAZUMA KIYOTANI, SHINOBU TOMOCHIKA, KEI FURUYA, MASAO NAKAJIMA, HIROTO MATSUI, YUKIO TOKUMITSU, YOSHITARO SHINDO, SHIN YOSHIDA, MICHIHISA IIDA, NOBUAKI SUZUKI, SHIGERU TAKEDA, TATSUYA IOKA, SHOICHI HAZAMA and HIROAKI NAGANO
    Anticancer Research February 2023, 43 (2) 613-620; DOI: https://doi.org/10.21873/anticanres.16197
  • Open Access
    The Latest Treatments for Cancer Cachexia: An Overview
    HAYATO WATANABE and TAKASHI OSHIMA
    Anticancer Research February 2023, 43 (2) 511-521; DOI: https://doi.org/10.21873/anticanres.16188
  • Open Access
    Treatment of Human Pancreatic Cancers Following Local and Systemic Administration of Oncolytic Adenovirus Serotype 35
    RYOSUKE ONO, KOSUKE TAKAYAMA, RIKA ONISHI, SORA TOKUOKA, FUMINORI SAKURAI and HIROYUKI MIZUGUCHI
    Anticancer Research February 2023, 43 (2) 537-546; DOI: https://doi.org/10.21873/anticanres.16190
  • You have access
    Lenvatinib Versus Sorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis
    GIOVANNI ANTONIO MARROCCO, MARIANNA SILLETTA, VINCENZO BIANCO, FRANCESCO MONDERA, CAROLINA SCIORTINO, LAURA PAPPALARDO, VALENTINA VIGLIALORO, ENRICO CORTESI, GIUSEPPE TONINI and SALVATORE CAPONNETTO
    Anticancer Research February 2023, 43 (2) 755-763; DOI: https://doi.org/10.21873/anticanres.16215
  • You have access
    Breaking Bad News During the COVID-19 Pandemic: A Systematic Review of the Literature
    GEORGIOS GOUMAS, NIKOLAOS SYRIGOS, ELENI FYTA, THEODOROS I. DARDAVESIS and EFFIE SIMOU
    Anticancer Research February 2023, 43 (2) 773-779; DOI: https://doi.org/10.21873/anticanres.16217
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention

Visit the official website of Anticancer Research.
Back to top
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire